Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NCT02009449

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Cancer, +64 more
Locations: UCLA Medical Hematology & Oncology Los Angeles, California, United States

UCSF San Francisco, California, United States

Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States

Florida Cancer Specialists & Research Institute Sarasota, Florida, United States

View Trial Details

Completed

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

NCT04773951

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
Locations: Fujian Provincial Cancer Hospital Fuzhou, Fujian, China

Tumor Hospital affiliated to Harbin Medical University Harbin, Heilongjiang, China

Hunan Cancer Hospital Changsha, Hunan, China

Nanjing Drum Tower Hospital Nanjing, Jiangsu, China

View Trial Details

Completed

Project HERO: Health Empowerment & Recovery Outcomes

NCT03345563

Conditions: Bladder Cancer, Colon Cancer, Colonic Diseases, +51 more
Locations: Rutgers University New Brunswick, New Jersey, United States

View Trial Details

Completed

the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors

NCT04718584

Conditions: Adenocarcinoma, Advanced Penile Carcinoma, Bladder Cancer, +18 more
Locations: Dragonboat Biopharmaceutical,Co.,Ltd Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer

NCT00403169

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma

NCT05256472

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health

NCT04000880

Conditions: Adnexal Diseases, Behavior, Blood Protein Disorders, +67 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of Tennessee Health Science Center Memphis, Tennessee, United States

View Trial Details

Completed

Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer

NCT02964078

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Cancer, +13 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study

NCT06339138

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor

NCT03239145

Conditions: Adnexal Diseases, Advanced Solid Tumor, Colonic Diseases, +37 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions